Established in 1963, this manufacturer specializes in producing hormones, steroids, and other pharmaceutical products in various dosage forms, including tablets, capsules, injections, and ophthalmic drops. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple international regulatory authorities, including the U.S. FDA, the Therapeutic Goods Administration (TGA) of Australia, and the Malta Medicines Authority (European Union). The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in multiple countries worldwide.